跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ULTRAFEN 12.5 SUPPOSITORY 12.5 mg - HSA Drug Approval Details
Approvals
/
HSA
/
ULTRAFEN 12.5 SUPPOSITORY 12.5 mg
Approved
THERAPEUTIC
ULTRAFEN 12.5 SUPPOSITORY 12.5 mg
BEXIMCO PHARMACEUTICALS LTD
🇸🇬 Health Sciences Authority
Approval Date
Dec 8, 1998
Approval ID
bc3c23efa04b26f7
Company
BEXIMCO PHARMACEUTICALS LTD
Type
Therapeutic
Approval Details
Approval Id
bc3c23efa04b26f7
Drug Name
ULTRAFEN 12.5 SUPPOSITORY 12.5 mg
Product Name
ULTRAFEN 12.5 SUPPOSITORY 12.5 mg
Approval Number
SIN10523P
Approval Date
1998-12-08
Registrant
PHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence Holder
PHARMATECH MEDICAL ENTERPRISE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SUPPOSITORY
Route Of Administration
RECTAL
Atc Code
M01AB05
Atc Item Name
diclofenac
Pharma Manufacturer Name
PHARMATECH MEDICAL ENTERPRISE PTE. LTD.
Company Detail Path
/organization/pharmatech-medical-enterprise-pte-ltd
Active Ingredients
DICLOFENAC SODIUM
12.5 mg
DICLOFENAC SODIUM
12.5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 8, 1998
Approval ID
bc3c23efa04b26f7
Type
Therapeutic
Back to HSA Approvals